Arete Wealth Advisors’s BlackRock Health Sciences Trust BME Stock Holding History
Bought
Maintained
Sold
Other funds holding BME
NRW
CA
Arete Wealth Advisors's BME Position: Q2 2023 in Review
Arete Wealth Advisors sold out of BlackRock Health Sciences Trust (BME) in Q2 2023, closing a stake of 12,177 shares — an estimated $510K sold.
Arete Wealth Advisors first reported a position in BME in Q2 2017 and held it in 21 quarters. The position peaked at $542M in Q4 2022. 69 funds tracked by Wall St. Rank hold BME as of Q2 2023.
- Arete Wealth Advisors reported no remaining BlackRock Health Sciences Trust position as of Q2 2023 after selling out during the quarter.
- Arete Wealth Advisors sold 12,177 BlackRock Health Sciences Trust shares in Q2 2023, an estimated $510K.
- Arete Wealth Advisors first reported a position in BlackRock Health Sciences Trust in Q2 2017 and held it in 21 quarters.
- Arete Wealth Advisors's BlackRock Health Sciences Trust position peaked at $542M in Q4 2022.
- 69 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q2 2023.
Based on Arete Wealth Advisors's 13F filing for Q2 2023, filed 9 Aug 2023.